StockData
bioAffinity Technologies, Inc. logo

bioAffinity Technologies, Inc. (BIAF) stock

BIAFNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAFW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3071% below fair value
$2.15+0.22 (+11.40%)

Close on Nov 18, 2026Market cap $17.42MP/E –Yield –

bioAffinity Technologies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

bioAffinity Technologies's total debt was $36.47K at Jun 30, 2026. For fiscal 2025 it was $41.31K, up 104.7% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$41.31K+104.7%
FY2024Dec 31, 2024$20.18K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$36.47K-20.6%
Q1 FY2026Mar 31, 2026$38.92K-19.2%
Q4 FY2025Dec 31, 2025$41.31K+104.7%
Q3 FY2025Sep 30, 2025$303.66K+103.6%
Q2 FY2025Jun 30, 2025$45.95K+101.8%
Q1 FY2025Mar 31, 2025$48.16K+109.0%
Q4 FY2024Dec 31, 2024$20.18K–
Q3 FY2024Sep 30, 2024$149.18K–
Q2 FY2024Jun 30, 2024$22.77K–
Q1 FY2024Mar 31, 2024$23.04K–

More bioAffinity Technologies figures

See a number that looks wrong?